المؤلفون: Gooding KM; Diabetes and Vascular Medicine, University of Exeter Medical School, Barrack Road, Exeter, EX2 5AX, UK. K.M.Gooding@exeter.ac.uk.; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK. K.M.Gooding@exeter.ac.uk., Lienczewski C; Department of Nephrology, University of Michigan, Ann Arbor, USA., Papale M; Department of Emergency and Organ Transplantation, Nephrology Unit, University of Bari Aldo Moro, Bari, Italy., Koivuviita N; Department of Medicine, Division of Nephrology, Turku University Hospital, Turku, Finland.; Turku PET Centre, University of Turku, Turku, Finland., Maziarz M; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Malmo, Sweden., Dutius Andersson AM; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Malmo, Sweden., Sharma K; Department of Imaging, Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK., Pontrelli P; Department of Emergency and Organ Transplantation, Nephrology Unit, University of Bari Aldo Moro, Bari, Italy., Garcia Hernandez A; Astellas Pharma Europe B.V, Meppel, The Netherlands., Bailey J; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Tobin K; Department of Renal Medicine and Renal Transplantation, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Saunavaara V; Department of Medical Physics, Division of Medical Imaging, Turku University Hospital, Turku, Finland., Zetterqvist A; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Malmo, Sweden., Shelley D; Leeds Teaching Hospitals NHS Trust, Leeds, UK.; Advanced Imaging Centre, University of Leeds, Leeds, UK., Teh I; Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK., Ball C; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Puppala S; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Ibberson M; Swiss Institute of Bioinformatics, Lausanne, Switzerland., Karihaloo A; Novo Nordisk Research Center Seattle, Inc., Seattle, USA., Metsärinne K; Department of Medicine, Division of Nephrology, Turku University Hospital, Turku, Finland., Banks RE; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Gilmour PS; The Drug Development Team, Leiden, The Netherlands., Mansfield M; Leeds Teaching Hospitals NHS Trust, Leeds, UK., Gilchrist M; Diabetes and Vascular Medicine, University of Exeter Medical School, Barrack Road, Exeter, EX2 5AX, UK., de Zeeuw D; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.; University of Groningen, Groningen, The Netherlands., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands.; University of Groningen, Groningen, The Netherlands., Nuutila P; Department of Medicine, Division of Nephrology, Turku University Hospital, Turku, Finland.; Turku PET Centre, University of Turku, Turku, Finland., Kretzler M; Department of Nephrology, University of Michigan, Ann Arbor, USA.; Computational Medicine and Bioinformatics, University of Michigan, Ann Arbour, USA., Welberry Smith M; Department of Renal Medicine and Renal Transplantation, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Gesualdo L; Department of Emergency and Organ Transplantation, Nephrology Unit, University of Bari Aldo Moro, Bari, Italy., Andress D; AbbVie, Scottsdale, USA., Grenier N; Service de Radiologie, CHU de Bordeaux, Université de Bordeaux, Bordeaux, France., Shore AC; Diabetes and Vascular Medicine, University of Exeter Medical School, Barrack Road, Exeter, EX2 5AX, UK.; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Gomez MF; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Malmo, Sweden., Sourbron S; Department of Imaging, Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.

مؤلفون مشاركون: BEAt-DKD consortium

المصدر: BMC nephrology [BMC Nephrol] 2020 Jun 29; Vol. 21 (1), pp. 242. Date of Electronic Publication: 2020 Jun 29.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967793 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2369 (Electronic) Linking ISSN: 14712369 NLM ISO Abbreviation: BMC Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2/*metabolism , Diabetic Nephropathies/*diagnostic imaging , Kidney/*diagnostic imaging , Renal Insufficiency, Chronic/*diagnostic imaging, Diabetes Mellitus, Type 1/complications ; Diabetes Mellitus, Type 1/metabolism ; Diabetes Mellitus, Type 2/complications ; Diabetic Nephropathies/etiology ; Diabetic Nephropathies/pathology ; Disease Progression ; Humans ; Kidney/blood supply ; Kidney/pathology ; Magnetic Resonance Imaging ; Observational Studies as Topic ; Oxygen Radioisotopes ; Positron-Emission Tomography ; Prognosis ; Prospective Studies ; Renal Circulation ; Renal Insufficiency, Chronic/etiology ; Renal Insufficiency, Chronic/pathology ; Ultrasonography

المؤلفون: Garcia-Vaz E; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Lund, Sweden., McNeilly AD; Division of Clinical and Molecular Medicine, Ninewells Hospital and University of Dundee, Dundee, U.K., Berglund LM; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Lund, Sweden., Ahmad A; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Lund, Sweden., Gallagher JR; Division of Clinical and Molecular Medicine, Ninewells Hospital and University of Dundee, Dundee, U.K., Dutius Andersson AM; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Lund, Sweden., McCrimmon RJ; Division of Clinical and Molecular Medicine, Ninewells Hospital and University of Dundee, Dundee, U.K., Zetterqvist AV; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Lund, Sweden., Gomez MF; Department of Clinical Sciences in Malmö, Lund University Diabetes Centre, Lund University, Lund, Sweden maria.gomez@med.lu.se f.khan@dundee.ac.uk., Khan F; Division of Clinical and Molecular Medicine, Ninewells Hospital and University of Dundee, Dundee, U.K. maria.gomez@med.lu.se f.khan@dundee.ac.uk.

المصدر: Diabetes [Diabetes] 2020 Mar; Vol. 69 (3), pp. 424-435. Date of Electronic Publication: 2019 Dec 05.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 0372763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1939-327X (Electronic) Linking ISSN: 00121797 NLM ISO Abbreviation: Diabetes Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Experimental/*physiopathology , Endothelium, Vascular/*drug effects , Microvessels/*drug effects , NFATC Transcription Factors/*antagonists & inhibitors , Pyrazoles/*pharmacology, Acetylcholine/pharmacology ; Animals ; Blood Pressure/drug effects ; Diabetes Mellitus, Experimental/genetics ; Diabetes Mellitus, Experimental/metabolism ; Endothelin-1/drug effects ; Endothelin-1/metabolism ; Endothelium, Vascular/metabolism ; Endothelium, Vascular/physiopathology ; Enzyme Inhibitors/pharmacology ; Insulin/genetics ; Interleukin-6/metabolism ; Iontophoresis ; Mice ; Microvessels/metabolism ; Microvessels/physiopathology ; NFATC Transcription Factors/drug effects ; NFATC Transcription Factors/metabolism ; NG-Nitroarginine Methyl Ester/pharmacology ; Nitric Oxide Synthase Type III/drug effects ; Nitric Oxide Synthase Type III/metabolism ; Nitroprusside/pharmacology ; Osteopontin/drug effects ; Osteopontin/metabolism ; Skin/blood supply ; Survival Rate ; Ultrasonography, Doppler ; Vasodilator Agents/pharmacology

المؤلفون: Blanco F; 1 Department of Clinical Sciences, Malmö, Lund University Diabetes Centre (LUDC), Lund University, Malmö, Sweden.; 2 Departamento de Biofísica, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay., Heinonen SE; 3 Bioscience, Cardiovascular, Renal and Metabolic diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca Gothenburg, Sweden., Gurzeler E; 4 A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland., Berglund LM; 1 Department of Clinical Sciences, Malmö, Lund University Diabetes Centre (LUDC), Lund University, Malmö, Sweden., Dutius Andersson AM; 1 Department of Clinical Sciences, Malmö, Lund University Diabetes Centre (LUDC), Lund University, Malmö, Sweden., Kotova O; 1 Department of Clinical Sciences, Malmö, Lund University Diabetes Centre (LUDC), Lund University, Malmö, Sweden., Jönsson-Rylander AC; 3 Bioscience, Cardiovascular, Renal and Metabolic diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca Gothenburg, Sweden., Ylä-Herttuala S; 4 A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.; 5 Heart Center, Kuopio University Hospital, Kuopio, Finland., Gomez MF; 1 Department of Clinical Sciences, Malmö, Lund University Diabetes Centre (LUDC), Lund University, Malmö, Sweden.

المصدر: Diabetes & vascular disease research [Diab Vasc Dis Res] 2018 Jul; Vol. 15 (4), pp. 302-313. Date of Electronic Publication: 2018 Mar 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Sage Publications Country of Publication: England NLM ID: 101234011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8984 (Electronic) Linking ISSN: 14791641 NLM ISO Abbreviation: Diab Vasc Dis Res Subsets: MEDLINE

مواضيع طبية MeSH: Plaque, Atherosclerotic*, Apolipoproteins B/*deficiency , Atherosclerosis/*prevention & control , Brachiocephalic Trunk/*drug effects , Insulin-Like Growth Factor II/*deficiency , NFATC Transcription Factors/*antagonists & inhibitors , Pyrazoles/*pharmacology , Receptors, LDL/*deficiency, Animals ; Apolipoprotein B-100 ; Apolipoproteins B/genetics ; Atherosclerosis/genetics ; Atherosclerosis/metabolism ; Atherosclerosis/pathology ; Brachiocephalic Trunk/metabolism ; Brachiocephalic Trunk/pathology ; Catalase/metabolism ; Cells, Cultured ; Diabetes Mellitus, Type 2/genetics ; Diabetes Mellitus, Type 2/metabolism ; Diabetes Mellitus, Type 2/pathology ; Disease Models, Animal ; Female ; Genetic Predisposition to Disease ; Insulin-Like Growth Factor II/genetics ; Male ; Mice, 129 Strain ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Knockout ; NADPH Oxidase 4/metabolism ; NFATC Transcription Factors/metabolism ; Oxidative Stress/drug effects ; Phenotype ; Receptors, LDL/genetics ; Signal Transduction